These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 20227473
1. T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes. Koide H, Asai T, Hatanaka K, Akai S, Ishii T, Kenjo E, Ishida T, Kiwada H, Tsukada H, Oku N. Int J Pharm; 2010 Jun 15; 392(1-2):218-23. PubMed ID: 20227473 [Abstract] [Full Text] [Related]
2. Particle size-dependent triggering of accelerated blood clearance phenomenon. Koide H, Asai T, Hatanaka K, Urakami T, Ishii T, Kenjo E, Nishihara M, Yokoyama M, Ishida T, Kiwada H, Oku N. Int J Pharm; 2008 Oct 01; 362(1-2):197-200. PubMed ID: 18586076 [Abstract] [Full Text] [Related]
3. PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner. Ishida T, Wang X, Shimizu T, Nawata K, Kiwada H. J Control Release; 2007 Oct 08; 122(3):349-55. PubMed ID: 17610982 [Abstract] [Full Text] [Related]
4. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection. Ishida T, Atobe K, Wang X, Kiwada H. J Control Release; 2006 Oct 27; 115(3):251-8. PubMed ID: 17045355 [Abstract] [Full Text] [Related]
5. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes. Ishida T, Ichihara M, Wang X, Kiwada H. J Control Release; 2006 Oct 27; 115(3):243-50. PubMed ID: 17011060 [Abstract] [Full Text] [Related]
6. Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon. Shimizu T, Ishida T, Kiwada H. Immunobiology; 2013 May 27; 218(5):725-32. PubMed ID: 22995937 [Abstract] [Full Text] [Related]
7. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. Wang X, Ishida T, Kiwada H. J Control Release; 2007 Jun 04; 119(2):236-44. PubMed ID: 17399838 [Abstract] [Full Text] [Related]
8. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. Ishida T, Kiwada H. Int J Pharm; 2008 Apr 16; 354(1-2):56-62. PubMed ID: 18083313 [Abstract] [Full Text] [Related]
9. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration. Abu Lila AS, Nawata K, Shimizu T, Ishida T, Kiwada H. Int J Pharm; 2013 Nov 01; 456(1):235-42. PubMed ID: 23928149 [Abstract] [Full Text] [Related]
10. CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes. Tagami T, Nakamura K, Shimizu T, Yamazaki N, Ishida T, Kiwada H. J Control Release; 2010 Mar 03; 142(2):160-6. PubMed ID: 19850094 [Abstract] [Full Text] [Related]
11. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. Ishida T, Ichihara M, Wang X, Yamamoto K, Kimura J, Majima E, Kiwada H. J Control Release; 2006 May 01; 112(1):15-25. PubMed ID: 16515818 [Abstract] [Full Text] [Related]
12. Repeated injections of PEGylated liposomal topotecan induces accelerated blood clearance phenomenon in rats. Ma Y, Yang Q, Wang L, Zhou X, Zhao Y, Deng Y. Eur J Pharm Sci; 2012 Apr 11; 45(5):539-45. PubMed ID: 22155543 [Abstract] [Full Text] [Related]
13. Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice. Ishida T, Ichikawa T, Ichihara M, Sadzuka Y, Kiwada H. J Control Release; 2004 Mar 24; 95(3):403-12. PubMed ID: 15023452 [Abstract] [Full Text] [Related]
14. Suppression in mice of immunosurveillance against PEGylated liposomes by encapsulated doxorubicin. Yahuafai J, Asai T, Nakamura G, Fukuta T, Siripong P, Hyodo K, Ishihara H, Kikuchi H, Oku N. J Control Release; 2014 Oct 28; 192():167-73. PubMed ID: 25041998 [Abstract] [Full Text] [Related]
15. Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production. Tagami T, Nakamura K, Shimizu T, Ishida T, Kiwada H. J Control Release; 2009 Aug 04; 137(3):234-40. PubMed ID: 19361546 [Abstract] [Full Text] [Related]
16. Size-dependent induction of accelerated blood clearance phenomenon by repeated injections of polymeric micelles. Koide H, Asai T, Kato H, Ando H, Shiraishi K, Yokoyama M, Oku N. Int J Pharm; 2012 Aug 01; 432(1-2):75-9. PubMed ID: 22562054 [Abstract] [Full Text] [Related]
17. Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice. Taguchi K, Urata Y, Anraku M, Watanabe H, Kadowaki D, Sakai H, Horinouchi H, Kobayashi K, Tsuchida E, Maruyama T, Otagiri M. Drug Metab Dispos; 2009 Nov 01; 37(11):2197-203. PubMed ID: 19679674 [Abstract] [Full Text] [Related]
18. Relationship between the concentration of anti-polyethylene glycol (PEG) immunoglobulin M (IgM) and the intensity of the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes in mice. Hashimoto Y, Shimizu T, Abu Lila AS, Ishida T, Kiwada H. Biol Pharm Bull; 2015 Nov 01; 38(3):417-24. PubMed ID: 25757923 [Abstract] [Full Text] [Related]
19. Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs. Suzuki T, Ichihara M, Hyodo K, Yamamoto E, Ishida T, Kiwada H, Ishihara H, Kikuchi H. Int J Pharm; 2012 Oct 15; 436(1-2):636-43. PubMed ID: 22850293 [Abstract] [Full Text] [Related]
20. Accelerated blood clearance of pegylated liposomal topotecan: influence of polyethylene glycol grafting density and animal species. Li C, Cao J, Wang Y, Zhao X, Deng C, Wei N, Yang J, Cui J. J Pharm Sci; 2012 Oct 15; 101(10):3864-76. PubMed ID: 22777607 [Abstract] [Full Text] [Related] Page: [Next] [New Search]